- Home
- ARQT vs WNC Comparison
ARQT vs WNC Comparison
Compare ARQT & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | WNC |
|---|---|---|
| Founded | 2016 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 363.8M |
| IPO Year | 2020 | 1991 |
Fundamental Metrics
Financial Performance| Metric | ARQT | WNC |
|---|---|---|
| Price | $28.85 | $8.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $24.83 | $9.00 |
| AVG Volume (30 Days) | ★ 1.8M | 598.3K |
| Earning Date | 10-28-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 6.15 |
| Revenue | $317,929,000.00 | ★ $1,638,115,000.00 |
| Revenue This Year | $85.51 | N/A |
| Revenue Next Year | $30.74 | $15.44 |
| P/E Ratio | ★ N/A | $1.45 |
| Revenue Growth | ★ 129.21 | N/A |
| 52 Week Low | $11.13 | $6.78 |
| 52 Week High | $31.77 | $17.55 |
Technical Indicators
Market Signals| Indicator | ARQT | WNC |
|---|---|---|
| Relative Strength Index (RSI) | 52.58 | 49.20 |
| Support Level | $27.71 | $8.60 |
| Resistance Level | $30.26 | $10.04 |
| Average True Range (ATR) | 1.06 | 0.30 |
| MACD | -0.24 | -0.10 |
| Stochastic Oscillator | 49.91 | 22.50 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.